Global Advanced Infusion Systems Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

November 2017 | 201 pages | ID: GE65C158FA3EN
Precision Business Insights (PBI)

Abstracts

Infusion systems are used to administer drugs or fluids in solution form to patient’s blood circulatory system in systemic, controlled, and precise manner. The various routes to administer the drug into patient's circulatory system include intravenous, subcutaneous, epidural, and arterial infusions are preferred based on the treatment requirement. Infusion systems were highly used for medical purpose but, owing to increase in mortality rates with infusion systems, companies focusing on the advanced infusion systems. Advanced infusion systems have found extensive acceptance and usage across various areas of disease management. Advanced infused systems are widely used because of their dependable, ergonomic design and easy-to-use features. Advanced infusion systems are extensively used in wide range of application areas including diabetes, oncology, enteral feeding, pain management, and general infusion. The advantage of advanced infusion systems is helping doctors to program and calculate dose delivery rates in a more efficient manner, enabling them to provide better patient care.

Global advanced infusion systems market is growing at a significant CAGR due to the increasing global prevalence of chronic diseases. An increase in prevalence and incidence of chronic diseases such as cancer, diabetes etc. is the key factor drives the global advanced infusion systems market growth. In addition, technological developments in advanced infusion systems which reduce the risks, increase in safety, bioavailability, and therapeutic effectiveness of drugs, and an increasing healthcare expenditure are the factors expected to fuel the global advanced infusion systems market over the forecast period. Similarly, increasing use of advanced infusion products in home care owing to favourable reimbursements, visual monitoring, mobility of the system, continues infusion for multiple medications at the same time, and patient safety are few factors fuel the advanced infusion systems market over the forecast period. However, lack of awareness in using advanced infusion systems expected to hinder the growth of global advanced infusion systems market. Apart from this, product recalls, possible medication errors associated with an infusion pump, and strict regulations for product approval are also some key factors might hamper the growth of global advanced infusion systems market over the forecast period.

The advanced infusion systems market has been segmented based on the product type, pumping channel, application, and end user

Based on product type, advanced infusion systems market is segmented into the following:

• Elastomeric infusion systems
• Volumetric infusion systems
• Large volume
• Small volume pump
• Disposable infusion systems
• Patient controlled analgesia pumps
• Syringe infusion systems
• Ambulatory infusion systems
• Implantable infusion systems

Based on pumping channel, advanced infusion systems market is segmented into the following:

• Single Channel Infusion Pumps
• Multiple Channel Infusion Pumps

Based on the application, advanced infusion systems market is segmented into the following:

• Diabetes
• Asthma
• Chemotherapy
• Pain management
• Clinical nutrition
• Others

Based on the end-user, advanced infusion systems market is segmented into the following:

• Hospitals
• Clinics
• Home care
• Ambulatory Surgical Centres
• Others

Global advanced infusion systems market is in developing stage, several local and international players are actively involved in the development and marketing of advanced infusion systems. In 2015, the volumetric infusion pumps dominated the global advanced infusion systems market due to the increasing demand for volumetric infusion pumps in hospitals, long-term acute care centres, clinics, and ambulatory surgery centres. Rising incidence rate of chronic disorders such as diabetes, cancer and increase in geriatric population are driving the growth of advanced infusion systems market over the forecast period. Rising malnutrition around the globe is expected to boost the demand for infusion pumps for clinical nutrition. Technological advancements are playing a major role in the growth of the global advanced infusion systems market. Players in the market are focusing on developing innovative products to gain a competitive edge. For instance, in 2013, Terumo launched the Terufusion advanced infusion system, the latest generation of infusion and syringe pumps, which is convenient handling for multiple infusions.

Geographically, global advanced infusion systems market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Middle East & Africa, and Latin America. North America commands significant share in the global advanced infusion systems market followed by Europe and Asia-Pacific. The largest share of North-America in global advanced infusion systems market is due to high adoption of ambulatory pumps in the management of chronic diseases, high prevalence chronic diseases like cancer (according to American National Cancer Institute, In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States) and well-established healthcare infrastructure in the region. Europe is the second largest region in the global advanced infusion systems market owing to increasing the prevalence of cancer disease (according to world cancer research fund international, In 2012, globally Denmark is the top country in the prevalence rate of cancer with 338 per 100,000 people and increasing significantly every year). Asia-Pacific region, particularly China and India, are expected to present substantial growth opportunities for advanced infusion systems market players over the forecast period which is mainly attributed to the huge patient population, increasing the incidence of chronic diseases with changing lifestyles, improving healthcare facilities, increasing accessibility to advanced products, and rising disposable income.

Some of the players in global advanced infusion systems market are Hospira, Inc. (Pfizer Inc.) (U.S.), AngioDynamics (U.S.), Becton, Dickinson and Company (U.S.), Animas Corporation (Johnson & Johnson) (U.S.), B. Braun Melsungen AG (Germany), Terumo Medical Corporation (Japan), Iartic Systems Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (U.S.), Baxter International Inc. (U.S.), and I-Flow Corporation (Kimberly-Clark) (U.S.) to name a few.

In 2016, Hospira and iatric systems partnered to deliver smart pump-EMR interoperability to hospitals

In 2012, Baxter has acquired Sigma International, for diversification of its product portfolio around the globe

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL ADVANCED INFUSION SYSTEMS MARKET INTRODUCTION

2.1. Global Advanced Infusion Systems Market– Taxonomy
2.2. Global Advanced Infusion Systems Market–Definitions
  2.2.1. Pumping Channel
  2.2.2. Product Type

3. GLOBAL ADVANCED INFUSION SYSTEMS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Advanced Infusion Systems Market Dynamics – Factors Impact Analysis
3.6. Global Advanced Infusion Systems Market– Recent Product Launches

4. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL ADVANCED INFUSION SYSTEMS MARKET, BY PUMPING CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Single Channel Infusion Pumps
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Multiple Channel Infusion Pumps
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis

6. GLOBAL ADVANCED INFUSION SYSTEMS MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Elastomeric Infusion Systems
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Volumetric Infusion Systems
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Disposable Infusion Systems
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Patient Controlled Analgesia Pumps
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Syringe Infusion Systems
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis
6.6. Ambulatory Infusion Systems
  6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.6.3. Market Opportunity Analysis
6.7. Implantable Infusion Systems
  6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.7.3. Market Opportunity Analysis

7. GLOBAL ADVANCED INFUSION SYSTEMS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Diabetes
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Asthma
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Chemotherapy
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Pain Management
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Clinical Nutrition
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Others
  7.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.6.3. Market Opportunity Analysis

8. GLOBAL ADVANCED INFUSION SYSTEMS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hospitals
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Clinics
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Home Care
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Ambulatory Surgical Centers
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Others
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis

9. GLOBAL ADVANCED INFUSION SYSTEMS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Advanced Infusion Systems Market- Opportunity Analysis Index - By Pumping Channel, By Product Type, By Application, By End User, and Region, 2017 – 2023

10. NORTH AMERICA ADVANCED INFUSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Pumping Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Single Channel Infusion Pumps
    10.1.1.2. Multiple Channel Infusion Pumps
  10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Elastomeric Infusion Systems
    10.1.2.2. Volumetric Infusion Systems
      10.1.2.2.1. Large Volume
      10.1.2.2.2. Small Volume
    10.1.2.3. Disposable Infusion Systems
    10.1.2.4. Patient Controlled Analgesia Pumps
    10.1.2.5. Syringe Infusion Systems
    10.1.2.6. Ambulatory Infusion Systems
    10.1.2.7. Implantable Infusion Systems
  10.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Diabetes
    10.1.3.2. Asthma
    10.1.3.3. Chemotherapy
    10.1.3.4. Pain Management
    10.1.3.5. Clinical Nutrition
    10.1.3.6. Others
  10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Hospitals
    10.1.4.2. Clinics
    10.1.4.3. Home Care
    10.1.4.4. Ambulatory Surgical Centers
    10.1.4.5. Others
  10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    10.1.5.1. U.S.
    10.1.5.2. Canada
  10.1.6. North America Advanced Infusion Systems Market- Opportunity Analysis Index - By Pumping Channel, By Product Type, By Application, By End User, and Country, 2017 – 2023
  10.1.7. North America Advanced Infusion Systems Market Dynamics – Trends

11. EUROPE ADVANCED INFUSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Pumping Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Single Channel Infusion Pumps
    11.1.1.2. Multiple Channel Infusion Pumps
  11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Elastomeric Infusion Systems
    11.1.2.2. Volumetric Infusion Systems
      11.1.2.2.1. Large Volume
      11.1.2.2.2. Small Volume
    11.1.2.3. Disposable Infusion Systems
    11.1.2.4. Patient Controlled Analgesia Pumps
    11.1.2.5. Syringe Infusion Systems
    11.1.2.6. Ambulatory Infusion Systems
    11.1.2.7. Implantable Infusion Systems
  11.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Diabetes
    11.1.3.2. Asthma
    11.1.3.3. Chemotherapy
    11.1.3.4. Pain Management
    11.1.3.5. Clinical Nutrition
    11.1.3.6. Others
  11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.4.1. Hospitals
    11.1.4.2. Clinics
    11.1.4.3. Home Care
    11.1.4.4. Ambulatory Surgical Centers
    11.1.4.5. Others
  11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.5.1. Germany
    11.1.5.2. UK
    11.1.5.3. France
    11.1.5.4. Spain
    11.1.5.5. Italy
    11.1.5.6. Russia
    11.1.5.7. Poland
    11.1.5.8. Rest of Europe
  11.1.6. Europe Advanced Infusion Systems Market- Opportunity Analysis Index - By Pumping Channel, By Product Type Type, By Application, By End User, and Country, 2017 – 2023
  11.1.7. Europe Advanced Infusion Systems Market Dynamics – Trends

12. ASIA-PACIFIC ADVANCED INFUSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Pumping Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Single Channel Infusion Pumps
    12.1.1.2. Multiple Channel Infusion Pumps
  12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Elastomeric Infusion Systems
    12.1.2.2. Volumetric Infusion Systems
      12.1.2.2.1. Large Volume
      12.1.2.2.2. Small Volume
    12.1.2.3. Disposable Infusion Systems
    12.1.2.4. Patient Controlled Analgesia Pumps
    12.1.2.5. Syringe Infusion Systems
    12.1.2.6. Ambulatory Infusion Systems
    12.1.2.7. Implantable Infusion Systems
  12.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Diabetes
    12.1.3.2. Asthma
    12.1.3.3. Chemotherapy
    12.1.3.4. Pain Management
    12.1.3.5. Clinical Nutrition
    12.1.3.6. Others
  12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Hospitals
    12.1.4.2. Clinics
    12.1.4.3. Home Care
    12.1.4.4. Ambulatory Surgical Centers
    12.1.4.5. Others
  12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    12.1.5.1. Japan
    12.1.5.2. China
    12.1.5.3. India
    12.1.5.4. ASEAN
    12.1.5.5. Australia & New Zealand
    12.1.5.6. Rest of Asia-Pacific
  12.1.6. Asia-Pacific Advanced Infusion Systems Market- Opportunity Analysis Index - By Pumping Channel, By Product Type Type, By Application, By End User, and Country, 2017 – 2023
  12.1.7. Asia-Pacific Advanced Infusion Systems Market Dynamics – Trends

13. LATIN AMERICA ADVANCED INFUSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Pumping Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.1.1. Single Channel Infusion Pumps
    13.1.1.2. Multiple Channel Infusion Pumps
  13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Elastomeric Infusion Systems
    13.1.2.2. Volumetric Infusion Systems
      13.1.2.2.1. Large Volume
      13.1.2.2.2. Small Volume
    13.1.2.3. Disposable Infusion Systems
    13.1.2.4. Patient Controlled Analgesia Pumps
    13.1.2.5. Syringe Infusion Systems
    13.1.2.6. Ambulatory Infusion Systems
    13.1.2.7. Implantable Infusion Systems
  13.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Diabetes
    13.1.3.2. Asthma
    13.1.3.3. Chemotherapy
    13.1.3.4. Pain Management
    13.1.3.5. Clinical Nutrition
    13.1.3.6. Others
  13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.4.1. Hospitals
    13.1.4.2. Clinics
    13.1.4.3. Home Care
    13.1.4.4. Ambulatory Surgical Centers
    13.1.4.5. Others
  13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.5.1. Brazil
    13.1.5.2. Mexico
    13.1.5.3. Argentina
    13.1.5.4. Venezuela
    13.1.5.5. Rest of Latin America
  13.1.6. Latin America Advanced Infusion Systems Market- Opportunity Analysis Index - By Pumping Channel, By Product Type Type, By Application, By End User, and Country, 2017 – 2023
  13.1.7. Latin America Advanced Infusion Systems Market Dynamics – Trends

14. MIDDLE EAST & AFRICA ADVANCED INFUSION SYSTEMS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  14.1.1. Pumping Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.1.1. Single Channel Infusion Pumps
    14.1.1.2. Multiple Channel Infusion Pumps
  14.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.2.1. Elastomeric Infusion Systems
    14.1.2.2. Volumetric Infusion Systems
      14.1.2.2.1. Large Volume
      14.1.2.2.2. Small Volume
    14.1.2.3. Disposable Infusion Systems
    14.1.2.4. Patient Controlled Analgesia Pumps
    14.1.2.5. Syringe Infusion Systems
    14.1.2.6. Ambulatory Infusion Systems
    14.1.2.7. Implantable Infusion Systems
  14.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.3.1. Diabetes
    14.1.3.2. Asthma
    14.1.3.3. Chemotherapy
    14.1.3.4. Pain Management
    14.1.3.5. Clinical Nutrition
    14.1.3.6. Others
  14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.4.1. Hospitals
    14.1.4.2. Clinics
    14.1.4.3. Home Care
    14.1.4.4. Ambulatory Surgical Centers
    14.1.4.5. Others
  14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.5.1. Gulf Cooperation Council (GCC) Countries
    14.1.5.2. Israel
    14.1.5.3. South Africa
    14.1.5.4. Rest of MEA
  14.1.6. MEA Advanced Infusion Systems Market- Opportunity Analysis Index - By Pumping Channel, By Product Type Type, By Application, By End User, and Country, 2017 – 2023
  14.1.7. MEA Advanced Infusion Systems Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Hospira, Inc. (Pfizer Inc.) (U.S.)
  15.2.2. AngioDynamics (U.S.)
  15.2.3. Becton, Dickinson and Company (U.S.)
  15.2.4. Animas Corporation (Johnson & Johnson) (U.S.)
  15.2.5. B. Braun Melsungen AG (Germany)
  15.2.6. Terumo Medical Corporation (Japan)
  15.2.7. Iartic Systems Inc. (U.S.)
  15.2.8. F. Hoffmann-La Roche Ltd (Switzerland)
  15.2.9. Medtronic (U.S.)
  15.2.10. Baxter International Inc. (U.S.)
  15.2.11. I-Flow Corporation (Kimberly-Clark) (U.S.)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS